Mobic (Meloxicam)

Meloxicam, the active ingredient in Mobic, is a NSAID (Oxicam) presented as an oral tablet for oral use. It is used to relieve pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain. GNH USA supplies Mobic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mobic (meloxicam) acts on inflammatory pathways to reduce pain and swelling in several musculoskeletal conditions. - Osteoarthritis: improves joint function and reduces chronic pain. - Rheumatoid arthritis: decreases inflammatory activity and joint damage. - Ankylosing spondylitis: alleviates spinal stiffness and pain. - Acute pain: provides rapid relief of short‑term inflammatory pain.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Peripheral edema: swelling of the lower limbs. - Skin rash: mild erythema or itching. - Elevated blood pressure.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Hepatotoxicity: signs of liver injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: reduced kidney function. - Anaphylaxis: rare systemic allergic response. - Cardiovascular events: increased risk of thrombotic events.

Before prescribing meloxicam, clinicians should assess individual risk factors and monitor therapy. - Cardiovascular risk: avoid in patients with uncontrolled hypertension or recent myocardial infarction. - Gastrointestinal safety: use cautiously in those with a history of ulcers or bleeding. - Renal function: monitor serum creatinine in patients with existing kidney disease. - Hepatic monitoring: check liver enzymes periodically. - Pregnancy and lactation: assess benefit‑risk ratio; use only if clearly needed. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Meloxicam may interact with several drug classes, requiring clinical vigilance.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Lithium: elevated lithium serum levels.

Moderate Interactions (Monitor Closely):\n- Methotrexate: potential for enhanced toxicity. - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: monitor for fluid and electrolyte disturbances.